3tyf: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3tyf.jpg|left|200px]] | |||
The | <!-- | ||
The line below this paragraph, containing "STRUCTURE_3tyf", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
--> | |||
{{STRUCTURE_3tyf| PDB=3tyf | SCENE= }} | |||
===Crystal structure of a CD1d-lysophosphatidylcholine reactive iNKT TCR=== | |||
<!-- | |||
The line below this paragraph, {{ABSTRACT_PUBMED_22395072}}, adds the Publication Abstract to the page | |||
(as it appears on PubMed at http://www.pubmed.gov), where 22395072 is the PubMed ID number. | |||
--> | |||
{{ABSTRACT_PUBMED_22395072}} | |||
==About this Structure== | |||
[[3tyf]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3TYF OCA]. | |||
==Reference== | |||
<ref group="xtra">PMID:022395072</ref><references group="xtra"/> | |||
[[Category: Escherichia coli]] | |||
[[Category: Adams, E J.]] | |||
[[Category: Lopez-Sagaseta, J.]] | |||
[[Category: Antigen recognition]] | |||
[[Category: Cd1d]] | |||
[[Category: Immune system]] | |||
[[Category: Immunoglobulin-like]] | |||
[[Category: Membrane]] | |||
Revision as of 09:16, 25 April 2012
Crystal structure of a CD1d-lysophosphatidylcholine reactive iNKT TCR
Template:ABSTRACT PUBMED 22395072
About this Structure
3tyf is a 4 chain structure with sequence from Escherichia coli. Full crystallographic information is available from OCA.
Reference
- Lopez-Sagaseta J, Sibener LV, Kung JE, Gumperz J, Adams EJ. Lysophospholipid presentation by CD1d and recognition by a human Natural Killer T-cell receptor. EMBO J. 2012 Mar 6;31(8):2047-59. doi: 10.1038/emboj.2012.54. PMID:22395072 doi:10.1038/emboj.2012.54
